Jolinn Tripp
Gerontology · Quincy, ILNPI 1275060154
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 104 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 25 manufacturers, the largest accounting for just 23.7% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $726 and has fallen 65.8% since, to $248 in 2025.
Across 104 payments — averaging $18.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$445
- AstraZeneca$270
- Bayer$150
- Lilly USA, LLC$119
- Boehringer Ingelheim$107
- Pfizer$103
- plus $683 from 19 others
What the payments were for
- Food & beverage$1,877100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 22 | $445 |
| AstraZeneca | 15 | $270 |
| Bayer | 9 | $150 |
| Lilly USA, LLC | 7 | $119 |
| Boehringer Ingelheim | 6 | $107 |
| Pfizer | 6 | $103 |
| Abbott | 5 | $103 |
| Novartis | 5 | $81 |
| Otsuka America Pharmaceutical, Inc. | 4 | $70 |
| AbbVie | 3 | $63 |
| Novo Nordisk | 4 | $62 |
| Axsome Therapeutics, Inc. | 3 | $58 |
| GSK | 2 | $35 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $33 |
| Radius Health, Inc. | 1 | $26 |
| Dexcom, Inc. | 1 | $20 |
| Sanofi-aventis U.S. LLC | 1 | $19 |
| Astellas Pharma US Inc | 1 | $17 |
| Merck | 1 | $17 |
| Johnson & Johnson | 1 | $16 |
| E.r. Squibb & Sons, L.L.C. | 1 | $16 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $15 |
| Mylan Specialty L.p. | 1 | $15 |
| Ironshore Pharmaceuticals Inc. | 1 | $14 |
| Sumitomo Pharma America, Inc. | 1 | $4 |
How this compares
$1,877 in reported general payments places this provider in the 85th percentile of 180 gerontology providers in Illinois.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 74 | $84,302 |
| TrulicityDulaglutide | 56 | $53,501 |
| MounjaroTirzepatide | 40 | $45,923 |
| Nurtec OdtRimegepant Sulfate | 21 | $34,258 |
| EliquisApixaban | 40 | $30,787 |
| XareltoRivaroxaban | 23 | $28,465 |
| JanuviaSitagliptin Phosphate | 33 | $26,400 |
| JardianceEmpagliflozin | 34 | $24,686 |
| Bydureon BciseExenatide Microspheres | 21 | $17,878 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 21 | $15,698 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 21 | $13,647 |
| Spiriva HandihalerTiotropium Bromide | 16 | $9,349 |
| LinzessLinaclotide | 15 | $7,522 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 249 | $7,368 |
| Incruse ElliptaUmeclidinium Bromide | 22 | $7,307 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCTrulicity, Mounjaro | $119 | $99,42496 claims |
| Novo NordiskOzempic | $62 | $84,30274 claims |
| PfizerNurtec Odt, Eliquis | $103 | $65,04661 claims |
| Boehringer IngelheimJardiance, Spiriva Respimat | $107 | $30,47145 claims |
| Johnson & JohnsonXarelto | $16 | $28,46523 claims |
| GSKTrelegy Ellipta, Incruse Ellipta, Breo Ellipta | $35 | $27,69755 claims |
| MerckJanuvia | $17 | $26,40033 claims |
| AstraZenecaBreztri Aerosphere | $270 | $13,64721 claims |
| AbbVieLinzess, Synthroid | $63 | $8,49831 claims |
| BayerKerendia | $150 | $7,20211 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 180 gerontology providers in Illinois.
Other gerontology in Quincy
- Joseph StokesChicago$16K
- Stephanie VerderameRockford$15K
- Megan BonisNiles$15K
- Cheryl RogersKankakee$15K
- June LosurdoHinsdale$9K
- Hayley MillsMoline$7K
- Carlyn NewellOlympia Fields$7K
- Ann WaldronMatteson$6K
- Kristin RyanArlington Heights$6K
- Rhonda JohnsonRockford$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.